Expand / Collapse search
Watch TV
Menu

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.

TERROR

"Blind Sheik" guilty of 1990s terror plots dies in US prison

Associated Press
Published | Updated
  • 4a406c94-
    Image 1 of 2

    FILE - This April 6, 1993 file photo shows Sheik Omar Abdel-Rahman in New York. Kenneth McKoy of the Federal Correction Complex in Butner, N.C., said Abdel-Rahman died Saturday, Feb. 18, 2017, after a long battle with diabetes and coronary artery disease. Abdel-Rahman was sentenced to life in prison after his 1995 conviction for his advisory role in a plot to blow up landmarks, including the United Nations, and several bridges and tunnels. (AP Photo/ Mark Lennihan, file) (The Associated Press)

  • 9dee0342-
    Image 2 of 2

    FILE - In this Feb. 26, 2012 file photo, Egyptian protesters hold posters showing Sheikh Omar Abdel-Rahman, who is imprisoned in the US, and call for his release outside a court in Cairo, Egypt. Abdel-Rahman died , Saturday, Feb. 18, 2017 after suffering from diabetes and coronary artery disease, said Kenneth McKoy at the Federal Correction Complex in Butner, N. C. (AP Photo/Khalil Hamra) (The Associated Press)

A federal prison official says blind Egyptian cleric Sheik Omar Abdel-Rahman who serving a life sentence in the United States in connection with a failed plot to blow up landmarks in New York City has died.

Abdel-Rahman died early Saturday. He was 78. Abdel-Rahman was sentenced to life in prison after his 1995 conviction for his advisory role in a plot to blow up landmarks, including the United Nations, and several bridges and tunnels.

Kenneth McKoy of the Federal Correction Complex in Butner, North Carolina, said Rahman died at 5:40 a.m. after a long battle with diabetes and coronary artery disease.